Indications
| Mesh Heading | Maximum Phase | Reference |
|---|---|---|
| Infarction; Myocardial Infarction; Ventricular Dysfunction; Ventricular Dysfunction, Left | Phase 1 | ClinicalTrials |
| Fibrosis; Liver Cirrhosis | Phase 2 | ClinicalTrials |
| Diabetes Mellitus, Type 2 | Phase 1 | ClinicalTrials |
| Spinal Cord Injuries; Wounds and Injuries | Phase 2 | ClinicalTrials |
| Diabetes Mellitus; Peripheral Arterial Disease; Peripheral Vascular Diseases | Phase 1/Phase 2 | ClinicalTrials |
| Diabetic Foot; Ischemia | Phase 1/Phase 2 | ClinicalTrials |
| Diabetes Mellitus; Diabetes Mellitus, Type 1 | Phase 1/Phase 2 | ClinicalTrials |
| Cardiomyopathies; Cardiomyopathy, Dilated | Phase 1/Phase 2 | ClinicalTrials |
| Spinal Cord Injuries; Wounds and Injuries | Phase 1/Phase 2 | ClinicalTrials |
| Cardiomyopathies; Infarction; Ischemia; Myocardial Infarction | Phase 1/Phase 2 | ClinicalTrials |
| Muscular Dystrophies; Muscular Dystrophy, Duchenne | Phase 1 | ClinicalTrials |
| Drug-Related Side Effects and Adverse Reactions; Psoriasis | Phase 1/Phase 2 | ClinicalTrials |
| Osteoarthritis | Phase 1/Phase 2 | ClinicalTrials |
| Autistic Disorder | Phase 1/Phase 2 | ClinicalTrials |
| Fibrosis; Liver Cirrhosis | Phase 1/Phase 2 | ClinicalTrials |
| Diabetic Foot; Ischemia; Peripheral Arterial Disease; Peripheral Vascular Diseases; Vascular Diseases | Phase 1 | ClinicalTrials |
| Spinal Cord Injuries; Wounds and Injuries | Phase 2 | ClinicalTrials |
| Multiple Sclerosis; Sclerosis | Phase 1/Phase 2 | ClinicalTrials |
| Osteoarthritis; Osteoarthritis, Knee | Phase 1 | ClinicalTrials |
| Spinal Cord Injuries; Wounds and Injuries | Phase 2 | ClinicalTrials |
| Colitis; Colitis, Ulcerative; Ulcer | Phase 1/Phase 2 | ClinicalTrials |
| Arthritis; Arthritis, Rheumatoid | Phase 1/Phase 2 | ClinicalTrials |
CONTENTS